Alexandra B. Hogan

4.4k total citations · 1 hit paper
49 papers, 1.7k citations indexed

About

Alexandra B. Hogan is a scholar working on Infectious Diseases, Epidemiology and Modeling and Simulation. According to data from OpenAlex, Alexandra B. Hogan has authored 49 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 18 papers in Epidemiology and 18 papers in Modeling and Simulation. Recurrent topics in Alexandra B. Hogan's work include COVID-19 epidemiological studies (18 papers), Respiratory viral infections research (15 papers) and Vaccine Coverage and Hesitancy (15 papers). Alexandra B. Hogan is often cited by papers focused on COVID-19 epidemiological studies (18 papers), Respiratory viral infections research (15 papers) and Vaccine Coverage and Hesitancy (15 papers). Alexandra B. Hogan collaborates with scholars based in United Kingdom, Australia and United States. Alexandra B. Hogan's co-authors include Azra C. Ghani, Peter Winskill, Oliver J. Watson, Gregory Barnsley, Jaspreet Toor, Fenella J. Kirkham, Vijeya Ganesan, Anne Gordon, Elizabeth Isaacs and Hannah C. Moore and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Alexandra B. Hogan

45 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global impact of the first year of COVID-19 vaccination: a mathematical modelling study

2022 882 citations Oliver J. Watson, Gregory Barnsley et al. The Lancet Infectious Diseases profile →

Peers

Countries citing papers authored by Alexandra B. Hogan

Since Specialization

Citations

This map shows the geographic impact of Alexandra B. Hogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandra B. Hogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandra B. Hogan more than expected).

Fields of papers citing papers by Alexandra B. Hogan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandra B. Hogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandra B. Hogan. The network helps show where Alexandra B. Hogan may publish in the future.

Co-authorship network of co-authors of Alexandra B. Hogan

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandra B. Hogan. A scholar is included among the top collaborators of Alexandra B. Hogan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandra B. Hogan. Alexandra B. Hogan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Estimating the impact of Western Australia's first respiratory syncytial virus immunisation program for all infants: A mathematical modelling study 2025 ·Vaccine ·(unknown), Alexandra B. Hogan, Ewan R. Cameron, Huong Le, Cara Minney–Smith, Peter Richmond, Christopher C. Blyth, Kathryn Glass, Hannah C. Moore	1
2	Quantifying the impact of a broadly protective sarbecovirus vaccine in a future SARS-X pandemic 2025 ·Nature Communications ·Charles Whittaker, Gregory Barnsley, Daniela Olivera Mesa, Victoria Cox, Daniel J. Laydon, Chee Wah Tan, Feng Zhu, Rob Johnson, Patrick Doohan, Lilith K. Whittles, Gemma Nedjati‐Gilani, Peter Winskill, Alexandra B. Hogan, Arminder Deol, (unknown), Katharina Hauck, David Chien Lye, Lin‐Fa Wang, Oliver J. Watson, Azra C. Ghani	0
3	Modelling the epidemiological impact of maternal respiratory syncytial virus (RSV) vaccination in Australia 2024 ·Vaccine ·(unknown), Anthony T. Newall, David Muscatello, Alexandra B. Hogan, James Wood	3
4	Modelling the impact of hybrid immunity on future COVID-19 epidemic waves 2024 ·BMC Infectious Diseases ·Thao P. Le, (unknown), (unknown), Patricia T. Campbell, Alexandra B. Hogan, (unknown), Jodie McVernon, Ivo Müeller, James R. Walker, Christopher M. Baker	1
5	Modelling respiratory syncytial virus age-specific risk of hospitalisation in term and preterm infants 2024 ·BMC Infectious Diseases ·(unknown), Alexandra B. Hogan, Mohinder Sarna, Kathryn Glass, Hannah C. Moore	3
6	Impact of COVID-19 vaccination programmes in Europe: lives saved and lessons learned 2024 ·The Lancet Respiratory Medicine ·Oliver J. Watson, Alexandra B. Hogan	1
7	Impact of the 100 days mission for vaccines on COVID-19: a mathematical modelling study 2024 ·The Lancet Global Health ·Gregory Barnsley, Daniela Olivera Mesa, Alexandra B. Hogan, Peter Winskill, (unknown), Damian Walker, Azra C. Ghani, Oliver J. Watson	6
8	Report from the World Health Organization’s immunization and vaccines related implementation research advisory committee (IVIR-AC) meeting, Geneva, 11–13 September 2023 2024 ·Vaccine ·Philipp Lambach, Walt Orenstein, Sheetal Silal, Alyssa N. Sbarra, (unknown), Rakesh Aggarwal, Habib Hasan Farooqui, Stefan Flasche, Alexandra B. Hogan, Sun‐Young Kim, Julie Leask, Paula M. Luz, (unknown), William J. Moss, Virginia E. Pitzer, X. Sean Wang, Joseph T. Wu	6
9	Estimating long-term vaccine effectiveness against SARS-CoV-2 variants: a model-based approach 2023 ·Nature Communications ·Alexandra B. Hogan, Patrick Doohan, Sean L. Wu, Daniela Olivera Mesa, Jaspreet Toor, Oliver J. Watson, Peter Winskill, Giovanni Charles, Gregory Barnsley, Eleanor M. Riley, David S. Khoury, Neil M. Ferguson, Azra C. Ghani	15
10	Modeling the impact of COVID‐19 nonpharmaceutical interventions on respiratory syncytial virus transmission in South Africa 2023 ·Influenza and Other Respiratory Viruses ·(unknown), Cécile Viboud, Bryan T. Grenfell, Alexandra B. Hogan, Stefano Tempia, Anne von Gottberg, Jocelyn Moyes, Sibongile Walaza, C. Hansen, Cheryl Cohen, Rachel E. Baker	9
11	Global impact of the first year of COVID-19 vaccination: a mathematical modelling study breakdown → 2022 ·The Lancet Infectious Diseases ·Oliver J. Watson, Gregory Barnsley, Jaspreet Toor, Alexandra B. Hogan, Peter Winskill, Azra C. Ghani	882
12	Modelling the impact of vaccine hesitancy in prolonging the need for Non-Pharmaceutical Interventions to control the COVID-19 pandemic 2022 ·SHILAP Revista de lepidopterología ·Daniela Olivera Mesa, Alexandra B. Hogan, Oliver J. Watson, Giovanni Charles, Katharina Hauck, Azra C. Ghani, Peter Winskill	42
13	Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis 2021 ·Vaccine ·Alexandra B. Hogan, Peter Winskill, Oliver J. Watson, Patrick Walker, Charles Whittaker, Marc Baguelin, Nicholas F. Brazeau, Giovanni Charles, Katy A. M. Gaythorpe, Arran Hamlet, Edward Knock, Daniel J. Laydon, John A. Lees, Alessandra Løchen, Robert Verity, Lilith K. Whittles, Farzana Muhib, Katharina Hauck, Neil M. Ferguson, Azra C. Ghani	72
14	Analysis of the potential for a malaria vaccine to reduce gaps in malaria intervention coverage 2021 ·Malaria Journal ·H. Juliette T. Unwin, Lazaro Mwandigha, Peter Winskill, Azra C. Ghani, Alexandra B. Hogan	11
15	A Systematic Review of the Costs Relating to Non-pharmaceutical Interventions Against Infectious Disease Outbreaks 2021 ·Applied Health Economics and Health Policy ·Janetta Skarp, Laura Downey, Julius Ohrnberger, Lucia Cilloni, Alexandra B. Hogan, (unknown), (unknown), Hiral Shah, (unknown), Katharina Hauck	6
16	Modelling population-level impact to inform target product profiles for childhood malaria vaccines 2018 ·BMC Medicine ·Alexandra B. Hogan, Peter Winskill, Robert Verity, Jamie T. Griffin, Azra C. Ghani	8
17	Potential impact of a maternal vaccine for RSV: A mathematical modelling study 2017 ·Vaccine ·Alexandra B. Hogan, Patricia T. Campbell, Christopher C. Blyth, Faye J. Lim, Parveen Fathima, Stephanie Davis, Hannah C. Moore, Kathryn Glass	38
18	Time series analysis of RSV and bronchiolitis seasonality in temperate and tropical Western Australia 2016 ·Epidemics ·Alexandra B. Hogan, Robert Anderssen, Stephanie Davis, Hannah C. Moore, Faye J. Lim, Parveen Fathima, Kathryn Glass	36
19	Modelling the Seasonal Epidemics of Respiratory Syncytial Virus in Young Children 2014 ·PLoS ONE ·Hannah C. Moore, Peter Jacoby, Alexandra B. Hogan, Christopher C. Blyth, G. N. Mercer	40
20	Modelling the seasonality of respiratory syncytial virus in young children 2013 ·Piantadosi, J., Anderssen, R.S. and Boland J. (eds) MODSIM2013, 20th International Congress on Modelling and Simulation ·Alexandra B. Hogan, G. N. Mercer, Kathryn Glass, Hannah C. Moore	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact